Share Graph – Esperite

Search for:

Home
Contact

Esperite Group
News & Press Releases
Presentations & Policies
Financial Information
- Financial Calendar
- Financial Reports
Shareholder Information
Corporate Governance

Share Graph

Search for:

Recent Publications

Categories

Financial Reports (64)
Group News (376)
Press Clippings (22)

Archives

Archives

Calendar

October 2018
M	T	W	T	F	S	S
« Sep
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30	31

Recent News

ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 22nd tranche of investment today
Esperite N.V. (ESP): Sale by Esperite of stake in Cryo-Save South Africa cancelled
ESPERITE N.V. (ESP) WITH CRYOSAVE READY TO STORE MORE THAN A MILLION SAMPLES IN ITS NEW DESIGNED CRYOSTORAGE FACILITY IN GENEVA.
Esperite N.V. (ESP) : Update to the market on the publica-tion of the Annual Report 2017.
ESPERITE (ESP) : European Select Growth Opportunities Fund subscribes to the 21st tranche of investment today

Tags

Acquisition AGM Agreement Annual Report Appointment Board Change CEO Cerebral Palsy CryoSave Delayed EGM Esperite European Select Growth Opportunities Fund Evi Mattil Extracellular vesicles Financial Reports Financial Results France Frederic Amar Genoma India Investment Johan Goossens L1 Capital Marc Waeterschoot Martin Lampshire New Funding NYSE Euronext Amsterdam Packed Tranches PDMR PDRM Q1 Q3 Salveo Shareholders Shareholding Shares South Africa Stem Cell Bank Stem Cells Storage Switzerland The Cell Factory Umbilical Cord Blood Warrants

Contact Information

Esperite N.V. - Herengracht 282
1016 BX Amsterdam - The Netherlands

Tel. +31 (0) 575 548 998
Email: ir@esperite.com

Important Links

Cryo-Save Consumer Site
Cryo-Save Labs Site
Salveo Consumer Site
Genoma Consumer Site

PDF Downloads

Annual Report 2016
Prospectus
Admission Document
Expert Report

Subscribe

Please click here to subscribe for our press releases.

© 2016 Esperite N.V. - All rights reserved

Home
Media Center
Terms of Use
Contact